Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 24 of Cardiff Oncology, Inc.'s SEC filings and found 4 warrant series, 1 convertible, 2 ATM programs, 3 shelf registrations and 2 completed offerings on file for CRDF. The latest dilution event on file is ATM sales on Aug 26, 2026. Analysis updated Oct 27, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
NMADNOMAD Power Solutions, Inc.
CGTXCognition Therapeutics, Inc.
MAIAMAIA Biotechnology, Inc.
TENXTenax Therapeutics, Inc.
CINGCingulate Inc.
FBIOFortress Biotech, Inc.
CSBRChampions Oncology, Inc.
RANIRani Therapeutics Holdings, Inc.
TELOTelomir Pharmaceuticals, Inc. Common Stock
ACRVAcrivon Therapeutics, Inc. Common Stock
MNOVMediciNova, Inc.
APLMApollomics, Inc.
SPROSpero Therapeutics, Inc.
COYACoya Therapeutics, Inc.
VRCAVerrica Pharmaceuticals Inc.